Back to the complete issue
Wednesday, 13 November 2019

House could pass Clinical Trials Act by December

LEGISLATION WATCH- House aims to pass Clinical Trials Act by December: The special committee formed in the House of Representatives to discuss President Abdel Fattah El Sisi’s objections on the Clinical Trials Act is in the process of drafting an amended version of the bill, Deputy House Speaker El Sayed El Sherif said, according to Youm7. The committee will then refer the final draft of the proposed legislation to parliament’s plenary session for review, with the aim of finalizing any outstanding issues and holding a final vote by next month, according to El Sherif.

Background: It's been over a year since House Speaker Ali Abdel Aal ordered the establishment of a sub-committee to review the law regulating medical research and clinical trials. The law had passed during the previous legislative session, but El Sisi refused to sign the bill into law, citing concerns over several clauses, including provisions that set harsh penalties for the transfer of human research samples outside of Egypt without government approval. El Sisi said these provisions could be problematic for future scientific exchange with other countries.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.